[
    [
        {
            "time": "2021-Q3",
            "original_text": "凯莱英2021年三季报点评：业绩符合我们预期，公司未来发展有望不断提速【东吴医药朱国广团队】",
            "features": {
                "keywords": [
                    "凯莱英",
                    "三季报",
                    "业绩",
                    "预期",
                    "未来发展"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英2021年三季报点评：业绩符合我们预期，公司未来发展有望不断提速【东吴医药朱国广团队】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "基金最新“十大抱团股”名单出炉！",
            "features": {
                "keywords": [
                    "基金",
                    "抱团股",
                    "名单"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "基金最新“十大抱团股”名单出炉！",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "凯莱英(002821)季报点评：内修外练繁花已开 业绩进入加速释放期",
            "features": {
                "keywords": [
                    "凯莱英",
                    "季报",
                    "内修外练",
                    "业绩",
                    "加速释放"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英(002821)季报点评：内修外练繁花已开 业绩进入加速释放期",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "信达证券发布凯莱英研报：业绩超预期增长，内生外延推动平台化升级",
            "features": {
                "keywords": [
                    "信达证券",
                    "凯莱英",
                    "研报",
                    "业绩",
                    "超预期",
                    "平台化升级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "信达证券发布凯莱英研报：业绩超预期增长，内生外延推动平台化升级",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "资本动态｜凯莱英三季度：营收净利双增，产能扩建，却遭高瓴再度减持 股份",
            "features": {
                "keywords": [
                    "凯莱英",
                    "三季度",
                    "营收净利",
                    "双增",
                    "产能扩建",
                    "高瓴",
                    "减持"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "资本动态｜凯莱英三季度：营收净利双增，产能扩建，却遭高瓴再度减持 股份",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "平安证券给予凯莱英强烈推荐评级，Q3业绩表现理想，产能释放加速逻辑兑现",
            "features": {
                "keywords": [
                    "平安证券",
                    "凯莱英",
                    "强烈推荐",
                    "Q3",
                    "业绩",
                    "产能释放"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "平安证券给予凯莱英强烈推荐评级，Q3业绩表现理想，产能释放加速逻辑兑现",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "高瓴再度大幅减持“CDMO王者” 又退出一家医药白马十大流通股东之列",
            "features": {
                "keywords": [
                    "高瓴",
                    "减持",
                    "CDMO",
                    "医药白马",
                    "流通股东"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴再度大幅减持“CDMO王者” 又退出一家医药白马十大流通股东之列",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-Q3",
            "original_text": "安信证券给予凯莱英买入-A评级：订单充足且产能快速投放，2021Q3业绩增长超预期",
            "features": {
                "keywords": [
                    "安信证券",
                    "凯莱英",
                    "买入-A",
                    "订单充足",
                    "产能投放",
                    "业绩增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安信证券给予凯莱英买入-A评级：订单充足且产能快速投放，2021Q3业绩增长超预期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]